INX
Incannex Healthcare Ltd
Phase 2
Estimated
IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide
Obstructive Sleep Apnea (OSA)
T-minus 297 days
~ Apr 30, 2027
ClinicalTrials.gov
verified 15h ago
Countdown card →